Source:http://linkedlifedata.com/resource/pubmed/id/10879810
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-11-3
|
pubmed:abstractText |
The development of amniotic fluid turbidity during the third trimester is a known marker of fetal lung maturity. We hypothesized that this turbidity results from detachment of vernix caseosa from the fetal skin secondary to interaction with pulmonary-derived phospholipids in the amniotic fluid. To test this hypothesis, we exposed vernix to bovine-derived pulmonary surfactant over a physiologically relevant concentration range. Ten milligrams of vernix was evenly applied to the interior walls of 1.5-mL polypropylene microfuge tubes. Surfactant phospholipids were added to the tubes followed by slow rotation at 37 degrees C overnight. The liquid was decanted and spectrophotometrically analyzed at 650 nm to detect solution turbidity due to vernix detachment and/or emulsification. Increasing concentrations of surfactant phospholipids produced a dose-dependent increase in solution turbidity. A phospholipid mixture closely approximating natural pulmonary surfactant but devoid of surfactant-associated proteins yielded no increase. In other studies, the flow properties of vernix were studied in a Haake flow rheometer at 23 degrees C and 37 degrees C. There was a marked temperature-dependent effect with lower stress required to elicit flow at 37 degrees C compared with 23 degrees C. This temperature dependence was also demonstrated in the turbidity assay with a 124% increase in turbidity at body temperature compared with room temperature. We conclude that under in vitro conditions, pulmonary surfactant interacts with vernix resulting in detachment from a solid phase support. We speculate that in utero, this phenomenon contributes to the increase in amniotic fluid turbidity that is observed near term.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0031-3998
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
120-4
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10879810-Amniotic Fluid,
pubmed-meshheading:10879810-Animals,
pubmed-meshheading:10879810-Cattle,
pubmed-meshheading:10879810-Humans,
pubmed-meshheading:10879810-Infant, Newborn,
pubmed-meshheading:10879810-Lung,
pubmed-meshheading:10879810-Nephelometry and Turbidimetry,
pubmed-meshheading:10879810-Phospholipids,
pubmed-meshheading:10879810-Pulmonary Surfactants,
pubmed-meshheading:10879810-Skin Physiological Phenomena,
pubmed-meshheading:10879810-Vernix Caseosa
|
pubmed:year |
2000
|
pubmed:articleTitle |
Interaction between pulmonary surfactant and vernix: a potential mechanism for induction of amniotic fluid turbidity.
|
pubmed:affiliation |
Division of Neonatology and Skin Sciences Institute, Children's Hospital Research Foundation, University of Cincinnati, Ohio 45267-0541, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|